These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 5491205)

  • 41. [Dynamics of circulating anti-tissue antibodies and titer of rheumatoid factor in rheumatoid polyarthritis under the effect of immunosuppressive drugs, antimalarials and gold salts].
    Andreev T; Kozhukharova M; Pilosof T
    Vutr Boles; 1972; 11(3):125-8. PubMed ID: 4547886
    [No Abstract]   [Full Text] [Related]  

  • 42. [Clinico-immunological analysis of D-penicillamine use in rheumatoid arthritis].
    Benenson EV; Alibekova RI; Seĭsenbaev ASh; Cherkasskiĭ LA; Ivanova RL
    Vopr Revm; 1980; (4):27-31. PubMed ID: 6972667
    [No Abstract]   [Full Text] [Related]  

  • 43. [Generalized osteoporosis in chronic polyarthritis].
    Wittenborg A; Nicksch E; Degner D
    Z Rheumatol; 1989; 48 Suppl 1():44-5. PubMed ID: 2588823
    [No Abstract]   [Full Text] [Related]  

  • 44. [D-Penicillamine. A contribution on the therapy of chronic progressive polyarthritis].
    Kohlhardt I; Miehlke K
    Med Welt; 1968 Apr; 17():1130-3. PubMed ID: 5727879
    [No Abstract]   [Full Text] [Related]  

  • 45. [Long-term course of chronic polyarthritis under basic drug therapy].
    Mattern H; Leiendecker U; Krahe T; Harder T
    Dtsch Med Wochenschr; 1988 Mar; 113(12):453-8. PubMed ID: 3349944
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Obliterating bronchiolitis during D-penicillamine treatments].
    Chebat J; Seigneur F; Lechien J; Menkes CJ; Simon F; Martin JL
    Nouv Presse Med; 1980 Oct; 9(36):2655. PubMed ID: 7433056
    [No Abstract]   [Full Text] [Related]  

  • 47. [Study of various parameters of cellular and humoral immunity during the treatment of rheumatoid polyarthritis with D-penicillamine].
    Crouzet J; Guillien P; Boullenger C; Camus JP; Lièvre JA
    Rev Rhum Mal Osteoartic; 1972 Oct; 39(10):601-7. PubMed ID: 5083696
    [No Abstract]   [Full Text] [Related]  

  • 48. [Drug and physical therapy of primary chronic polyarthritis].
    Chlud K
    Med Klin; 1972 Apr; 67(17):593-6. PubMed ID: 4338786
    [No Abstract]   [Full Text] [Related]  

  • 49. [D-penicillamine in the treatment of rheumatoid polyarthritis].
    Santamaria A; Barcelo P; Menchon M; Ripoll M; Ruiz de la Torre R
    Rev Esp Reum Enferm Osteoartic; 1976; 19(2):133-79. PubMed ID: 785553
    [No Abstract]   [Full Text] [Related]  

  • 50. [A chemically induced polyneuropathy in chronic polyarthritis treated with D-penicillamine?].
    Mayr N; Graninger W; Wessely P
    Wien Klin Wochenschr; 1983 Feb; 95(3):86-8. PubMed ID: 6305039
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Indices of nonspecific resistance in the basic therapy of rheumatoid arthritis].
    Ivanova RL; Benenson EV; Ushkats LK; Gershel' ZE
    Ter Arkh; 1981; 53(7):75-7. PubMed ID: 7292321
    [No Abstract]   [Full Text] [Related]  

  • 52. [Basic treatment of rheumatoid arthritis].
    Domljan Z
    Reumatizam; 1974; 21(3):96-101. PubMed ID: 4831520
    [No Abstract]   [Full Text] [Related]  

  • 53. [Comparative results of treating active, long-neglected infectious nonspecific polyarthritis under hospital conditions].
    Wawrzyńska-Pagowska I; Graff-Wróblewska T; Juszczyk T; Michalski I; Pakula A
    Vopr Revm; 1973; 13(1):76-9. PubMed ID: 4776797
    [No Abstract]   [Full Text] [Related]  

  • 54. Cyclosporine A in rheumatoid arthritis: results at 30 months.
    Madhok R; Capell HA
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):248-52. PubMed ID: 3132774
    [No Abstract]   [Full Text] [Related]  

  • 55. [100 cases of common rheumatoid polyarthritis, treated with D-penicillamin].
    Camus JP; Crouzet J; Guillien P; Benichou C; Lievre JA
    Ann Med Interne (Paris); 1974 Jan; 125(1):9-28. PubMed ID: 4603018
    [No Abstract]   [Full Text] [Related]  

  • 56. [Efficacy of D-penicillamine and methotrexate in the treatment of rheumatoid arthritis in relation to levels of circulating rheumatoid factors of different classes].
    Zborovskiĭ AB; Sivordova LE; Derevianko LI; Zborovskaia IA; Zavodovskiĭ BV
    Ter Arkh; 1999; 71(1):60-3. PubMed ID: 10097305
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Our experience with D penicillamine in the treatment of rheumatoid polyarthritis].
    D'Eshougues JR; Delcambre B; Siame JL; Barbot V; Brion M; Duquesnoy B; Alsac J; Dulieu R
    Lille Med; 1978 Apr; 23(4):259-63. PubMed ID: 651557
    [No Abstract]   [Full Text] [Related]  

  • 58. [Physiopathology of rheumatoid polyarthritis for today's and tomorrow's therapists].
    Amor B
    Rev Prat; 1986 Dec; 36(57):3407-12. PubMed ID: 3809942
    [No Abstract]   [Full Text] [Related]  

  • 59. [The effect of D-penicillamine on the course of chronic polyarthritis].
    Miehlke K
    Acta Med Austriaca; 1975; 2(4):127-9. PubMed ID: 1224929
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Minimal changes nephrotic syndrome associated to penicillamine treatment].
    Basterrechea MA; de Arriba G; García-Martín F; Sánchez-Heras M; Giménez-Vega E; Sánchez J
    Nefrologia; 2004; 24(2):183-7. PubMed ID: 15219094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.